A Clinical Study of SKLB1028 Capsule in the Treatment of Recurrence/Refractory AML Patients

Clinical trial NCT04015024 · UNKNOWN

Trial details

NCT number: NCT04015024
Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia

Start date: 2019-07-01
Primary completion: 2021-04-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.